iotrolan has been researched along with Prosthesis Durability in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Poorter, JJ | 1 |
| Tolboom, TC | 1 |
| Rabelink, MJ | 1 |
| Pieterman, E | 1 |
| Hoeben, RC | 1 |
| Nelissen, RG | 1 |
| Huizinga, TW | 1 |
1 other study available for iotrolan and Prosthesis Durability
| Article | Year |
|---|---|
Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954.
Topics: Adenoviridae; Aged; Antineoplastic Agents; Aziridines; Cell Death; Cell Survival; Cells, Cultured; C | 2005 |